Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell CarcinomaSean M. McBride, Nancy Y. Lee, Eric J. Sherman et al.|Journal of Clinical Oncology|2020Cited by 393
Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients With Metastatic <i>EGFR</i>-Mutant Lung CancersHelena A. Yu, Mark G. Kris, Hira Rizvi et al.|JAMA Oncology|2020Cited by 131